What is a Medication Guide? How to read one

Updated 2026-10-10 · Reviewed for accuracy by the EKO Labs team. Educational only; not medical advice.

Some prescription medicines come with a patient handout called a Medication Guide. It is written for patients, approved by the U.S. Food and Drug Administration (FDA), and the pharmacy must give it to you. This guide explains what a Medication Guide is, why only some medicines have one, how it is organized, and how it differs from other leaflets you may receive. It is general information, not medical advice.

Do not stop or change a prescription medicine on your own because of something you read in a Medication Guide; talk to your prescriber or pharmacist first. In an emergency, call 911.

What a Medication Guide is

Under federal rules (21 CFR 208.3), a Medication Guide is FDA-approvedFDA-approved the FDA reviewed the medicine's safety and effectiveness for a specific use. patient labeling. The drug company writes it, and FDA must approve it before it can be handed out (21 CFR 208.24(a)). It must be based on, and must not conflict with, the full prescribing informationPrescribing information (label) the official FDA document for a medicine, with its uses, warnings and side effects. that doctors and pharmacists use, and it must be written in nontechnical, understandable language that is not promotional (21 CFR 208.20(a)).

Why only some medicines have one

Not every prescription medicine needs a Medication Guide. FDA requires one when it decides that a medicine poses a serious and significant public health concern and at least one of these applies (21 CFR 208.1):

• patient information could help prevent serious side effects;
• the medicine has serious risks, compared with its benefits, that could affect your decision to use it or keep using it;
• the medicine is important to health and following the directions is crucial for it to work.

For example, the FDA-approved GLP-1GLP-1 (glucagon-like peptide-1) a hormone the gut releases after eating. It helps release insulin, slows stomach emptying and signals fullness. medicines Ozempic®, Wegovy®, Mounjaro®, Zepbound®, Victoza® and Trulicity® each have a Medication Guide, while Egrifta SV® and Vyleesi® come with a “Patient Information” leaflet and Instructions for Use instead (checked on FDA’s openFDA label database in October 2026).

Your right to get it

• The pharmacy (or anyone else who dispenses the medicine) must give the Medication Guide directly to you or the person picking up the medicine each time it is dispensed. The rule covers new prescriptions and refills (21 CFR 208.1(a) and 208.24(e)).
• FDA says the Medication Guide is given on paper, but you can ask for an electronic copy instead.
• In rare cases a prescriber may decide a patient should not receive it, but the pharmacy must still give it to any patient who asks for it (21 CFR 208.26(b)).
• You can also read Medication Guides free online on DailyMed (dailymed.nlm.nih.gov) and Drugs@FDA, usually at the end of the prescribing information.

How a Medication Guide is organized

The words “Medication Guide” appear at the top, followed by the brand and generic names and how to pronounce the name. The headings that apply to the medicine then follow in a set order (21 CFR 208.20(b)). Real guides may adapt the wording slightly, for example “How should I use…” for an injection.

1. What is the most important information I should know about (medicine)? The specific serious concern that made the Medication Guide necessary and what you should do about it, such as symptoms to watch for. If the medicine has a boxed warningBoxed warning the FDA's strongest warning, printed in a box on a medicine's label. GLP-1 medicines carry one about thyroid C-cell tumors., its topic usually appears here. Read this part first.
2. What is (medicine)? What it is approved to treat. It may only list uses that are in the official prescribing information.
3. Who should not take (medicine)? The contraindications, and what to do if one of them applies to you.
4. How should I take (medicine)? Why following the directions matters, special instructions, and what to do after an overdose or a missed dose.
5. What should I avoid while taking (medicine)? Activities, other medicines, foods, alcohol or tobacco to avoid, and important risks during pregnancy and breastfeeding or for children and older adults.
6. What are the possible or reasonably likely side effects of (medicine)? Side effects that are serious or common, any risk of dependence, and the statement “Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.”
7. General information: that medicines are sometimes prescribed for purposes other than those listed, that you should not use it for another condition or give it to other people, the manufacturer’s name and place of business, and the date of the latest revision.

Companies may add other headings when useful (21 CFR 208.20(b)(9)); for example, the Wegovy Medication Guide ends with a list of ingredients. The guide must carry the statement “This Medication Guide has been approved by the U.S. Food and Drug Administration.”

Medication Guide vs. other leaflets

• Prescribing information (often called the package insert): the full technical label for health professionals, including any boxed warning and the sections on contraindications, warnings and pregnancy.
• Patient Package Insert (often titled “Patient Information”): FDA-approved patient labeling. FDA requires it to be handed out only for oral contraceptives and estrogen products (21 CFR 310.501 and 310.515); for other medicines it is voluntary.
• Instructions for Use: step-by-step written and picture instructions for medicines that are complicated to use, such as injection pens, including preparation, storage and disposal. FDA notes that some of these are not FDA-approved.
• Pharmacy leaflet (consumer medication information): the sheet many pharmacies print and staple to the bag. It is written by other organizations, and FDA does not review or approve it.

In May 2023 FDA proposed a new one-page format of Medication Guide called Patient Medication Information (PMI). As of October 2026 it is still a proposed rule in the Federal Register, so today’s Medication Guides remain in use.

Compounded medicines

Compounded medicines are not FDA-approved, so they do not come with an FDA-approved Medication Guide. If you receive a compounded medicineCompounded medicine a version prepared by a licensed pharmacy for a specific patient's prescription. It is not itself FDA-approved., ask your prescriber and pharmacy for written information about its risks and how to use it safely, and how it relates to the FDA-approved product.

Tips for reading it

• Read it before your first dose and again with each refill; many guides say there may be new information. Check the revision date.
• Start with “What is the most important information I should know,” and note the symptoms that mean you should call your doctor.
• Keep it with your medicine or save the electronic copy.
• Medication Guides must be written in English (21 CFR 208.20(a)(1)). If English is not your first language, ask your pharmacist or prescriber to go over it with you.

Questions to ask your pharmacist

• Does this medicine have a Medication Guide, and is this the latest version?
• What are the most important warning signs I should watch for?
• Which other medicines, supplements or foods should I avoid?
• What should I do if I miss a dose?
• Can you send me an electronic copy?

Sources: 21 CFR 208.1, 208.3, 208.20, 208.24 and 208.26, and 21 CFR 310.501 and 310.515 (eCFR, current text, October 2026); FDA, “Patient Labeling Resources” (Medication Guides, Patient Package Inserts, Instructions for Use, Patient Medication Information); Federal Register, “Medication Guides: Patient Medication Information,” proposed rule, May 31, 2023; FDA Medication Guides and patient labeling for Ozempic, Wegovy, Mounjaro, Zepbound, Victoza, Trulicity, Egrifta SV and Vyleesi (openFDA, consulted October 2026). This guide is general information, not medical advice.